Dr. Robert Anthony Dorschner, MD

Dr. Dorschner practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Dorschner's NPI, 1306103924, was assigned on April 19, 2012. Dr. Dorschner graduated from UC San Diego School of Medicine in 2012. Dr. Dorschner holds California license A128567.

Dr. Dorschner's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Dorschner's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Dorschner is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorschner practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dorschner's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dorschner is board certified in dermatology by the American Board of Dermatology. Dr. Dorschner is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, psoriasis and scalp rash among the conditions Dr. Dorschner treats.

CMS data shows 787 Medicare services from Dr. Dorschner across 8 procedure codes in 2024, for 213 Medicare patients. Medicare paid $27,073 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 213 Medicare patients who saw Dr. Dorschner in 2024. The largest group is 65 to 74, with 83 patients. 70% of them have high blood pressure, and 66% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dorschner's median patient age at 59, with 44% women.

In 2024, Dr. Dorschner wrote 466 Medicare Part D claims for 113 patients. 76% of them were for generic drugs. CMS names the drug for 366 of them, across 14 drugs with 11 or more claims each, at $433,899 in total drug cost. In 2023, CMS named 382 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dorschner for performance year 2024, reported as part of a group. Dr. Dorschner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dorschner as offering telehealth. CMS counts 211 procedures of removal of skin lesions by Dr. Dorschner, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Dr. Dorschner, published from 2003 to 2025. 2007 was the busiest year, with 2. The most frequent topics are Antimicrobial Cationic Peptides, Cathelicidins and Skin. Dr. Dorschner has published most often in J Invest Dermatol. Dr. Dorschner's most frequent co-authors are Richard L. Gallo, MD, PhD, Victor Francois Nizet, MD and Alvin Bob Coda, MD.

CMS Open Payments shows 3 general payments to Dr. Dorschner from 2 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $226.

Dr. Dorschner graduated from UC San Diego School of Medicine in 2012.

Dr. Dorschner is in network with 13 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.